HER2 Intratumoral Heterogeneity Is Associated with Incomplete Response to Anti-HER2 Neoadjuvant Chemotherapy in HER2-Positive Breast Carcinoma

被引：0
|
作者：
Li, Zaibo
Nitta, Hiroaki
Hou, Yanjun
Banks, Peter
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
[2] Ventana Med Syst Inc, Tucson, AZ USA
来源：
MODERN PATHOLOGY | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
212
引用
收藏
页码：55A / 55A
页数：1
相关论文
共 50 条
  • [1] HER2 Intratumoral Heterogeneity Is Associated with Incomplete Response to Anti-HER2 Neoadjuvant Chemotherapy in HER2-Positive Breast Carcinoma
    Li, Zaibo
    Nitta, Hiroaki
    Hou, Yanjun
    Banks, Peter
    [J]. LABORATORY INVESTIGATION, 2017, 97 : 55A - 55A
  • [2] HER2 intratumoral heterogeneity is independently associated with incomplete response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma
    Hou, Yanjun
    Nitta, Hiroaki
    Wei, Lai
    Banks, Peter M.
    Portier, Bryce
    Parwani, Anil V.
    Li, Zaibo
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2017, 166 (02) : 447 - 457
  • [3] HER2 intratumoral heterogeneity is independently associated with incomplete response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma
    Yanjun Hou
    Hiroaki Nitta
    Lai Wei
    Peter M. Banks
    Bryce Portier
    Anil V. Parwani
    Zaibo Li
    [J]. Breast Cancer Research and Treatment, 2017, 166 : 447 - 457
  • [4] HER2 Intratumoral Heterogeneity is Associated with Distal Metastasis in HER2-positive Breast Carcinoma
    Shen, Tiansheng
    Nitta, Hiro
    Parwani, Anil
    Li, Zaibo
    [J]. MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 258 - 260
  • [5] HER2 Intratumoral Heterogeneity is Associated with Distal Metastasis in HER2-positive Breast Carcinoma
    Shen, Tiansheng
    Nitta, Hiro
    Parwani, Anil
    Li, Zaibo
    [J]. LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 258 - 260
  • [6] Response to anti-HER2 neoadjuvant chemotherapy in HER2-positive invasive breast cancers with different HER2 FISH patterns
    Lv, Hong
    Bai, Qian-Ming
    Li, Ming
    Cai, Meng-Yuan
    Zhou, Shu-Ling
    Liu, Yin
    Wang, Zhong-Hua
    Shui, Ruo-Hong
    Lu, Hong-Fen
    Xu, Xiao-Li
    Yu, Bao-Hua
    Tu, Xiao-Yu
    Bi, Rui
    Cheng, Yu-Fan
    Zhou, Xiao-Yan
    Shao, Zhi-Min
    Yang, Wen-Tao
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2024,
  • [7] Quantitative digital imaging analysis of HER2 immunohistochemistry predicts the response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma
    Aidan C. Li
    Jing Zhao
    Chao Zhao
    Zhongliang Ma
    Ramon Hartage
    Yunxiang Zhang
    Xiaoxian Li
    Anil V. Parwani
    [J]. Breast Cancer Research and Treatment, 2020, 180 : 321 - 329
  • [8] Quantitative digital imaging analysis of HER2 immunohistochemistry predicts the response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma
    Li, Aidan C.
    Zhao, Jing
    Zhao, Chao
    Ma, Zhongliang
    Hartage, Ramon
    Zhang, Yunxiang
    Li, Xiaoxian
    Parwani, Anil, V
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (02) : 321 - 329
  • [9] Pathologic complete response to neoadjuvant anti-HER2 therapy is associated with HER2 immunohistochemistry score in HER2-positive early breast cancer
    Chen, Hai-Long
    Chen, Qiang
    Deng, Yong-Chuan
    [J]. MEDICINE, 2021, 100 (44)
  • [10] Anti-HER2 neoadjuvant and adjuvant therapies in HER2 positive breast cancer
    Guarneri, V.
    Barbieri, E.
    Dieci, M. V.
    Piacentini, F.
    Conte, P.
    [J]. CANCER TREATMENT REVIEWS, 2010, 36 : S62 - S66
12345